Nora Medina Meleán

Corporate Medical Advisor for Seagen, PharmaMar, and Eli-Lilly. Mentored a team of 08 medical advisors/managers and 11 MSLs. Oriented to design the strategic medical framework and its execution in regional brand plans. Guidance and mentoring of affiliate medical teams. Medical writing. Develop medical materials for internal and external stakeholders. Conduct regional medical training in specific areas. Transform the new medical affairs mindset from silos to collaborative teamwork.

Led a team of three. Successfully launched Atezolizumab + Bevacizumab in Hepatocarcinoma. Conducted two early access programs with Polatuzumab vedotin and Ocrelizumab. Designed the pre-launch plan of Atezolizumab + Vemurafenib, and Cobimetinib- Melanoma. Conducted the feasibility evaluation plan-Phase IV study with ocrelizumab. Guided the Hungarian Triple Negative Breast Cancer medical training program. Projects: Global RWE medical education platform, and One Field Force- pharma and diagnostic division.

Led a team of 3 people. Developed and executed medical plans and activities to strengthen Adalimumab as the top-selling molecule in Inflammatory Bowel Disease, Rheumatology, Dermatology, and Ophthalmology. Conducted the Hepatitis C guidelines publication project. Learned fast and successfully conducted the affiliate in the Pharmacovigilance Regional Audit project. Mentored the feasibility evaluation plan for the global-sponsored RWE study in IBD Guided HCV medical activities in the Peruvian affiliate.

Created and executed medical plans and strategies for an existing product, maintaining it in the top five-selling in Her2 Breast cancer Conducted the pre-launch trastuzumab SC activities Medical support to Clinical Operations in monitoring a Phase III global-sponsored clinical study Pioneered the multidisciplinary approach to medical events Updated a standard operational procedure in cross-functional teamwork

Postgrade in Gastroenterology